For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-off values (ECVs) have only been proposed for a limited number of fungal species–antifungal agent combinations, with the result that clinical breakpoints are lacking for most emerging mould pathogens. In the current study, we have compiled minimum inhibitory concentration (MIC) data for 4869 clinical mould isolates and present full MIC distributions for amphotericin B, itraconazole, voriconazole, posaconazole, and caspofungin with these isolates which comprise 20 species/genera. In addition, we present the results of an assessment of the fungicidal activity of these same five antifungal agents against a panel of 123 mould isolates comprising 16...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical and Laboratory Standards Institute (CLSI) conditions for testing the susceptibilities of pa...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to com...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (o...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
a<p>minimum inhibitory concentration.</p>b<p>Number of fungal isolates.</p>c<p>Amphotericin B.</p>d<...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints have not been established for mold testing. Epidemiologic cutoff values (ECVs) ...
[[abstract]]This study compared the YeastOne and reference CLSI M38-A2 broth microdilution methods f...
Antifungal susceptibility testing was performed on 197 yeast isolates from the BCCM/IHEM biomedical ...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical and Laboratory Standards Institute (CLSI) conditions for testing the susceptibilities of pa...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to com...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (o...
We evaluated the in vitro activity of voriconazole, amphotericin B, and itraconazole against 192 cli...
a<p>minimum inhibitory concentration.</p>b<p>Number of fungal isolates.</p>c<p>Amphotericin B.</p>d<...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints have not been established for mold testing. Epidemiologic cutoff values (ECVs) ...
[[abstract]]This study compared the YeastOne and reference CLSI M38-A2 broth microdilution methods f...
Antifungal susceptibility testing was performed on 197 yeast isolates from the BCCM/IHEM biomedical ...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical and Laboratory Standards Institute (CLSI) conditions for testing the susceptibilities of pa...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...